New research is being presented at ASCO 2013, the annual meeting of the American Society of Clinical Oncology, from May 31-June 4 in Chicago. Find everything here that you need to know before and during the conference.

Watch Scientific Program Committee Chair Dr. Douglas Yee discuss how the 2013 ASCO Annual Meeting reflects the priorities and issues that affect every oncology professional:


Meeting Highlights

Cancer Care Costs: A Look at Patient Expectations

Involving Family in Cancer Treatment Decisions

Deciding on When to Operate in Lung Cancer

Family Physicians’ Care of Cancer Patients

Burnout Among Oncologists

News from the Meeting

Men’s Fitness in Middle Age Protects Against Cancer

Surveillance Imaging Ineffective in Detecting Lymphoma Relapse

Post-Surgery Surveillance Sufficient for Men with Stage I Seminoma

Anti-PD-L1 Drug Shows Promising Anti-Cancer Effects

Standard-Dose Radiation Best for Stage III NSCLC

Funding Cuts Threaten Modernization of Cancer Research

Is Nivolumab a ‘Breakthrough’ in Melanoma?

Growth Factor Improves Ipilimumab Efficacy in Melanoma

Pazopanib Improves PFS in Advanced Ovarian Cancer

Breakthrough in Rare Eye Cancer: First Drug That Works

Cetuximab Superior to Bevacizumab as First-Line Tx in CRC

Tamoxifen for 10 Years Has Benefits, Says aTTom

Bevacizumab Prolongs Survival in Advanced Cervical Cancer

Sorafenib Potent New Tx for Advanced Thyroid Cancer

Drug Combos Are the Future of Melanoma Treatment

Cancer Drug Shortages Spawn Workarounds

Cervical Cancer Screening With Vinegar Reduces Mortality

No Benefit to Bevacizumab for Newly Diagnosed Glioblastoma?

Novel Agent Shows Potential for Advanced Lung Cancer

Strong Case for Weekly Paclitaxel in Breast Cancer

Stop Using Calcium and Magnesium With Oxaliplatin

Targeted Duo Boosts OS in Melanoma

Herpes-Derived Tx for Melanoma?

Dual Immune Tx Tag Teams Melanoma

Sorafenib Halts Resistant Thyroid Cancer

Targeted Drug Tops Chemo for Lung Cancer

HPV-Oral Cancer Won’t Threaten Spouses

Screen for Clot Risk at Start of Chemo

GALAXY-1 ‘Proof of Principle’ in Lung Ca Tx

Actor’s Oral Sex Remarks May Aid HPV Prevention

Are CT Scans Needed for Lymphoma?

Targeted Agent Has Slim NSCLC Benefit

Agent May Be NSCLC ‘Game Changer’

Weekly Chemo Better in Ovarian Cancer


More from the Meeting


Annual Meeting Abstracts

Attendee Resource Center

Description of Session Types

Cancer Education Committee

Scientific Program Committee

Cancer Communications Committee

Meeting Program

NCI’s 24 Provocative Questions

Navigating the Annual Meeting

Key Dates

Digital Product Information and Help

Professional Networking Opportunities

Oncology Professionals Hall

Travel, Shuttle, and Chicago Information

Ancillary Events Directory

Pre-Annual Meeting Seminars

Evaluation and CME

Past Meetings